Ukraine to Introduce New Prescription-Drug Monitoring System

On July 4, 2013, the State Administration of Ukraine on Medicinal Products held a public test of a new prescription drug monitoring system aimed at preventing counterfeit medicines from entering the supply chain.

The implementation of this system has been made possible by coating each drug package with a unique two-dimensional GS1 DataMatrix barcode. The GS1 system has been tested in the European Union and recommended for use by the European Federation of Pharmaceutical Industries and Associations (EFPIA).

Ukraine and the EU are planning to gradually implement the new drug monitoring system in Ukraine by 2017.

In 2011, the EU published the Directive No. 2011/62/EU (“the Falsified Medicines Directive”) according to which drug manufacturers throughout the EU need to mark all registered medical products with a unique identifier. The Directive came into force in January 2013.

Prepared by: Maya Kryvoshei

For more information, please contact mail@petosevic.com.

Source: State Administration of Ukraine on Medicinal Products